Ex-OpenAI science lead Kevin Weil launches Warp Sciences with $215M to automate drug-discovery wet labs
Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup that trains robots to synthesize and test promising drug compounds. Weil announced on X that the company raised $215 million at an $865 million valuation. The round was led by Lightspeed, with participation from IVP, Premji Invest and Lux Capital. Warp Sciences aims to reshore labor-intensive molecule synthesis now outsourced to contractors in China, such as WuXi AppTec, and to reduce geopolitical supply-chain risk. This is business and funding news with no cybersecurity incident, vulnerability or threat activity described.
Linha do tempo
-
Ex-OpenAI science lead Kevin Weil launches Warp Sciences with $215M to automate drug-discovery wet labs
ler a análise desta fonte ocultar
Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup that trains robots to synthesize and test promising drug compounds. Weil announced on X that the company raised $215 million at an $865 million valuation. The round was led by Lightspeed, with participation from IVP, Premji Invest and Lux Capital. Warp Sciences aims to reshore labor-intensive molecule synthesis now outsourced to contractors in China, such as WuXi AppTec, and to reduce geopolitical supply-chain risk. This is business and funding news with no cybersecurity incident, vulnerability or threat activity described.